查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2010032

醫用塑膠市場：2026-2032年全球市場預測（按產品類型、材料、製造流程、應用和最終用戶分類）

Medical Plastics Market by Product, Material Type, Process Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，醫用塑膠市場價值將達到 398.2 億美元，到 2026 年將成長至 434.3 億美元，到 2032 年將達到 766.7 億美元，複合年成長率為 9.81%。

主要市場統計數據
基準年 2025 398.2億美元
預計年份：2026年 434.3億美元
預測年份 2032 766.7億美元
複合年成長率 (%) 9.81%

對醫用塑膠市場進行簡要概述，重點介紹需要經營團隊關注的技術、監管和供應鏈轉折點。

醫用塑膠市場正處於關鍵轉折點，快速的技術進步、日益嚴格的監管以及不斷變化的供應鏈動態共同塑造了這個市場。新材料的創新、精密製造技術的進步以及對一次性產品安全性的重新關注，共同為製造商、供應商和醫療機構帶來了機會和挑戰。相關人員正在重新評估產品的可靠性、生物相容性和滅菌適用性，同時也尋求經濟有效的途徑來維持供應的連續性和合規性。

材料創新、精密製造、監管壓力和供應鏈重組如何重新定義醫用塑膠製造商的策略重點。

醫用塑膠產業正經歷一系列變革，這些變革正在全面重塑競爭動態和業務重點。首先，小型化和功能整合化的發展趨勢正在加速精密射出成型和微流體組件的應用，迫使製造商投資高精度模具和品管系統。同時，聚合物配方也朝著兼顧耐滅菌性和降低萃取率及洗脫率的方向發展，使得材料選擇策略與最終用途檢驗週期更加緊密地結合。

由於關稅政策的變化導致採購複雜化、供應風險增加以及生產系統重組，各公司正在採取策略應對措施和營運調整。

美國2025年實施的新關稅體系將引入複雜的政策因素，影響整個價值鏈的採購決策、供應商談判立場和產品成本結構。雖然關稅主要影響進口樹脂、零件和成品組件，但其間接影響也將波及物流規劃、庫存策略和長期供應商關係。製造商和採購負責人正在重新評估關稅風險，具體措施包括：繪製材料清單（BOM）敏感性圖，尋找關稅豁免機會，並透過比較供應商轉移成本與關稅負擔承擔情況來評估淨收益。

透過多維細分整合分析，確定如何調整產品設計方案、材料選擇和製程能力，以滿足多樣化的臨床和商業性需求。

基於細分市場的洞察揭示了應用、產品、材料、工藝和最終用戶等維度上的差異化機會和風險概況。從應用觀點來看，市場涵蓋診斷、一次性產品和耗材、植入、醫療設備和醫療包裝，每種產品都有其獨特的技術和監管限制。在一次性產品和耗材方面，導管和管材需要高柔韌性和生物相容性；手套和手術鋪巾優先考慮阻隔性和觸感回饋；針頭和套管需要精確的表面光潔度和抗疲勞性；注射器和藥筒則依賴於尺寸穩定性和密封性。診斷和監測設備優先考慮低萃取率和光學透明度，而外科和治療設備通常需要特殊的聚合物混合物和可追溯性系統。

區域製造能力、管理體制和醫療保健採購實踐如何影響全球市場的戰術性採購和合規策略？

美洲、歐洲、中東和非洲以及亞太地區的製造能力、法規結構和醫療保健採購實踐差異顯著，因此區域趨勢仍然是策略規劃的核心。在美洲，成熟的供應鏈、強大的流程專業知識基礎以及大規模醫院網路帶來的集中需求，創造了有利於大規模生產和建立成熟的供應商夥伴關係的環境。在該地區營運的公司越來越注重整合品質系統和物流彈性，同時也考慮近岸外包以降低運輸風險。

在醫療塑膠領域，基於能力的差異化，包括精密製造、協作材料開發和供應鏈管治，決定了競爭優勢。

醫療塑膠產業的主要企業正透過在精密製造、材料科學和法規遵循基礎設施方面的定向投資來凸顯自身優勢。一些製造商優先發展微型組件製造能力和先進成型技術，以抓住診斷設備和微創治療領域不斷成長的市場機會；而另一些製造商則專注於薄膜、片材和包裝的創新，以滿足不斷變化的滅菌和阻隔性能要求。聚合物混配商和組件製造商之間的策略夥伴關係日益普遍，從而能夠共同開發針對特定加工條件和滅菌方法最佳化的樹脂等級。

在醫用塑膠領域，製造商和買家可以立即採取哪些實際有效的措施來增強韌性、加快產品開發並減少監管摩擦？

行業領導者應採取積極主動的方式，將洞察轉化為永續的競爭優勢。首先，優先投資於材料特性分析和滅菌驗證，以縮短設備整合上市時間，並減少下游流程的監管阻力。其次，建構能夠處理微尺度射出成型和二次組裝的軟性製造單元，以支援結合可重複使用和一次性組件的混合產品架構。第三，建構多層次的供應商生態系統，包括關鍵樹脂和組件的認證二級訊息，並制定正式的應急庫存策略，以降低貿易中斷和關稅相關成本波動帶來的風險。

我們透明、多方面的研究框架，結合了專家訪談、技術標準審查和供應鏈壓力測試，提供了與決策直接相關的見解。

本分析採用多面向研究途徑，結合對第一線專家的訪談、技術文獻綜述和跨產業流程評估，從中提煉出切實可行的見解。關鍵資訊包括與供應鏈經理、產品工程師和法規專家進行的結構化討論，從而獲得關於流程限制、材料性能權衡和區域採購趨勢的定性見解。此外，還仔細審查了技術文獻和標準指南，以確保材料聲明符合當前的滅菌和生物相容性要求，並檢驗了擠出、注塑、射出成型、熱成型和吹塑成型製造等工藝的工藝能力表徵。

將策略重點和能力要求整合起來，顯示公司應該如何協調其工程、監管和採購決策，以實現永續的韌性。

簡而言之，在材料創新、對製造精度要求、監管趨嚴以及貿易政策演變的驅動下，醫用塑膠產業正經歷重大的結構調整。在這種環境下取得成功，需要整合材料科學和工藝能力，加強供應商管治，並採取靈活的製造和籌資策略，以應對政策衝擊並維持產品品質。投資可滅菌聚合物、微成型技術和數位化可追溯性的公司，將更有能力滿足醫院、門診中心、檢查室和製藥廠商的多樣化需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 醫用塑膠市場：依產品分類

  • 吹塑成型件
  • 薄膜
  • 射出成型零件
    • 連接器和配件
    • 外殼和外罩
    • 微流體組件
  • 管子

第9章 醫用塑膠市場：依材料類型分類

  • 聚碳酸酯
  • 聚乙烯
  • 聚丙烯
  • 聚氯乙烯
  • 矽酮

第10章：依製造流程分類的醫用塑膠市場

  • 積層製造
  • 吹塑成型
  • 擠壓
  • 射出成型
  • 熱成型

第11章 醫用塑膠市場：依應用領域分類

  • 診斷
  • 一次產品和耗材
    • 導尿管
    • 手套和帷幔
    • 針頭和套管
    • 注射器和藥筒
  • 植入
  • 醫療設備
    • 診斷設備
    • 監控設備
    • 手術器械
    • 治療設備
  • 醫療包裝

第12章 醫用塑膠市場：依最終用戶分類

  • 門診手術中心
  • 居家醫療
  • 醫院
  • 檢查室
  • 製藥公司

第13章 醫用塑膠市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 醫用塑膠市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 醫用塑膠市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國醫用塑膠市場

第17章：中國醫用塑膠市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • BASF SE
  • Celanese Corporation
  • Covestro AG
  • Dow Inc.
  • DuPont de Nemours, Inc.
  • Eastman Chemical Company
  • Ensinger GmbH
  • Evonik Industries AG
  • Gerresheimer AG
  • Minnesota Rubber & Plastics, Inc.
  • Mitsubishi Chemical Corporation
  • Nolato AB
  • RAUMEDIC AG
  • RTP Company
  • Rochling SE & Co. KG
  • Saudi Basic Industries Corporation
  • Sekisui Chemical Co., Ltd.
  • Solvay SA
  • Teknor Apex Company
  • Westlake Chemical Corporation
Product Code: MRR-434CCDA04ECE

The Medical Plastics Market was valued at USD 39.82 billion in 2025 and is projected to grow to USD 43.43 billion in 2026, with a CAGR of 9.81%, reaching USD 76.67 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 39.82 billion
Estimated Year [2026] USD 43.43 billion
Forecast Year [2032] USD 76.67 billion
CAGR (%) 9.81%

A concise orienting overview of the medical plastics landscape that highlights technological, regulatory, and supply chain inflection points demanding executive attention

The market for medical-grade plastics is at a pivotal juncture shaped by rapid technological progress, heightened regulatory scrutiny, and shifting supply chain dynamics. Emerging material innovations, advances in precision manufacturing, and a renewed focus on single-use safety profiles have converged to create both risk and opportunity for manufacturers, suppliers, and healthcare providers. Stakeholders are recalibrating around product reliability, biocompatibility, and sterilization compatibility while seeking cost-effective pathways to sustain supply continuity and regulatory compliance.

This executive summary synthesizes key developments across applications, products, materials, processes, end users, and geographies to provide a coherent view of near-term strategic imperatives. It integrates observed changes in adoption patterns among hospitals, outpatient centers, laboratories, and pharmaceutical manufacturers, and places those behaviors in the context of manufacturing choices such as injection molding, extrusion, and additive manufacturing. The goal is to equip leaders with a clear, actionable understanding of where to allocate engineering effort, how to reconfigure supply relationships, and what regulatory and tariff-driven headwinds to anticipate, all while preserving product safety and performance fidelity.

How material innovation, precision manufacturing, regulatory pressure, and supply chain reconfiguration are collectively redefining strategic priorities for medical plastics manufacturers

The landscape for medical plastics is evolving through several transformative shifts that collectively reshape competitive dynamics and operational priorities. First, the push for miniaturization and functional integration is accelerating adoption of precision injection molded components and microfluidic parts, compelling manufacturers to invest in higher tolerance tooling and quality systems. At the same time, there is a parallel migration toward polymer formulations that balance sterilization resistance with reduced extractables and leachables, driving material selection strategies closer to end-use validation cycles.

Simultaneously, the interplay between single-use disposables and reusable device components is creating hybrid product architectures that require novel joining and sterilization approaches. Supply chain resilience is another defining vector: companies are diversifying supplier bases, qualifying alternate resin sources, and increasing onshoring or nearshoring of critical components to mitigate logistics bottlenecks and geopolitical risk. Finally, increased regulatory emphasis on device traceability and sustainability considerations is prompting investments in manufacturing data capture and recyclable polymer pathways. Together these shifts demand cross-functional responses that align material science, process engineering, and regulatory affairs toward faster, safer, and more adaptable product lifecycles.

Strategic responses and operational adjustments companies are adopting as tariff policy shifts create procurement complexity, supply risk, and incentives for production realignment

The introduction of newly calibrated tariffs in the United States in 2025 presents a complex policy overlay that influences sourcing decisions, supplier negotiation posture, and product cost structures across the value chain. While tariffs primarily affect imported resins, components, and finished assemblies, the indirect consequences extend to logistics planning, inventory strategies, and long-term supplier relationships. Manufacturers and purchasers are reassessing tariff exposure by mapping bill-of-materials sensitivity, identifying tariff-exempt classification opportunities, and evaluating the net benefit of supplier relocation versus tariff absorption.

In practice, tariff-driven cost pressures are accelerating conversations about vertical integration and nearshoring of critical production steps, particularly for high-value injection molded components and specialized tubing assemblies that are core to device performance. Procurement teams are also intensifying compliance and customs classification efforts to avoid inadvertent misclassification and to take advantage of any available preferential trade treatments. From an operational perspective, companies are prioritizing multi-sourcing arrangements, establishing contingency inventory buffers for time-sensitive disposables, and pursing contractual mechanisms to share tariff risk with partners. These strategic responses aim to preserve continuity of care and product availability while maintaining acceptable margin profiles under the new trade conditions.

A cross-dimensional segmentation synthesis revealing where product design choices, material selection, and process capabilities must align to meet diverse clinical and commercial requirements

Segmentation-driven insight reveals differentiated opportunities and risk profiles across application, product, material, process, and end-user dimensions. When viewing the market through the lens of application, diagnostics, disposables and consumables, implants, medical devices, and medical packaging each exhibit distinct engineering and regulatory constraints. Within disposables and consumables, catheters and tubing demand high flexural performance and biocompatibility, gloves and drapes prioritize barrier properties and tactile responsiveness, needles and cannulas require precise surface finish and fatigue resistance, and syringes and cartridges depend on dimensional stability and seal integrity. Diagnostic and monitoring devices emphasize low extractables and optical clarity, whereas surgical and therapeutic devices often necessitate specialized polymer blends and traceability systems.

Examining products, blow molded components, films and sheets, injection molded components, and tubing form the backbone of device construction. Injection molded components in particular-encompassing connectors and fittings, housings and casings, and microfluidic components-require exacting tolerances, validated molding cycles, and robust cleanroom integration, making supplier qualification rigorously technical. Material selection acts as a fundamental differentiator: polycarbonate is prized for optical clarity and impact resistance; polyethylene and polypropylene are valued for chemical inertness and cost-efficiency; polyvinyl chloride balances flexibility with processability; and silicone provides exceptional biocompatibility and thermal resilience. Each polymer family brings trade-offs in sterilization compatibility, extraction behavior, and long-term stability that must be reconciled with device function.

Process-type segmentation highlights the growing role of additive manufacturing for low-volume, high-complexity parts and the continuing primacy of blow molding, extrusion, injection molding, and thermoforming for higher-volume components. Additive approaches enable rapid iteration and tooling-free customization but require downstream validation for medical use, while conventional molding processes deliver consistent throughput and established qualification paths. Finally, end-user segmentation-spanning ambulatory surgery centers, home healthcare, hospitals, laboratories, and pharmaceutical manufacturers-drives design priorities and service-level expectations. Devices intended for home healthcare must prioritize ease of use and transportability, whereas hospital and laboratory applications often impose stricter sterilization, traceability, and compatibility requirements. Integrating these segmentation axes enables a granular assessment of where to invest in materials engineering, process capabilities, and supplier partnerships to meet differentiated clinical and commercial needs.

How regional manufacturing capabilities, regulatory regimes, and healthcare procurement behaviors are shaping tactical sourcing and compliance strategies across global markets

Regional dynamics remain central to strategic planning, as manufacturing capacity, regulatory frameworks, and healthcare procurement behaviors vary significantly across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, established supply chains, a strong base of process expertise, and concentrated demand from large hospital networks create an environment conducive to high-volume production and advanced supplier partnerships. Companies operating here increasingly focus on quality system integration and logistical resilience, while exploring nearshoring to reduce transit risk.

Across Europe, Middle East & Africa, regulatory harmonization, stringent biocompatibility standards, and progressive sustainability mandates influence material choices and product end-of-life strategies. Suppliers in this region often lead in recyclable polymer initiatives and in implementing comprehensive environmental management systems. Contrastingly, Asia-Pacific remains a hub for high-volume polymer processing capacity and rapid scaling, supported by extensive supplier ecosystems for raw resins, components, and aftermarket services. Market participants leveraging Asia-Pacific manufacturing must balance cost advantages with rigorous oversight on quality assurance and supplier qualification to ensure consistent compliance. Cross-region collaboration, including diversified sourcing and region-specific validation pathways, is therefore emerging as a best practice to reconcile cost, compliance, and continuity considerations.

Why capability-based differentiation in precision manufacturing, materials co-development, and supply chain governance determines competitive edge in medical plastics

Leading companies in the medical plastics ecosystem are distinguishing themselves through targeted investment in precision manufacturing, material science, and regulatory compliance infrastructures. Some manufacturers are prioritizing micro-component capabilities and advanced molding to capture growth in diagnostic devices and minimally invasive therapies, while others are doubling down on films, sheets, and packaging innovations to meet evolving sterilization and barrier performance requirements. Strategic partnerships between polymer formulators and component manufacturers are becoming more common, enabling co-development of resin grades optimized for specific processing windows and sterilization methods.

Organizational differentiation also stems from supply chain governance practices. Top-performing firms maintain rigorous supplier qualification programs, digital traceability systems, and contingency sourcing playbooks that reduce risk during disruptions. Investment in testing labs and biocompatibility expertise supports faster regulatory submissions and smoother audits. In addition, several companies are exploring modular manufacturing footprints that combine localized final assembly with distributed component fabrication to improve responsiveness to regional demand swings. Collectively, these company-level moves underscore a shift from commodity competition toward capability-based differentiation anchored in engineering depth, regulatory readiness, and resilient supply networks.

Practical, high-impact actions manufacturers and purchasers can take immediately to strengthen resilience, speed product development, and reduce regulatory friction in medical plastics

Industry leaders should take a proactive approach to translate insight into durable advantage. First, prioritize investments in materials characterization and sterilization validation to shorten time-to-market for device integrations and to reduce downstream regulatory friction. Second, build flexible manufacturing cells capable of handling both micro-scale injection molding and secondary assembly to support hybrid product architectures that combine reusable and single-use elements. Third, establish multi-tier supplier ecosystems that include qualified secondary sources for critical resins and components alongside formal contingency inventory strategies to mitigate trade disruptions and tariff-related cost volatility.

Additionally, embed digital traceability and quality analytics across production workflows to enable real-time decision making, faster corrective actions, and stronger audit readiness. Pursue strategic collaborations with polymer specialists to co-develop resin formulations that minimize extractables while preserving processability, and align those efforts with sustainability roadmaps that explore recyclable or lower-carbon polymer options where feasible. Finally, align commercial contracting with risk-sharing mechanisms that address tariff exposure and supply variability, and ensure procurement, engineering, and regulatory teams jointly own supplier qualification criteria to accelerate onboarding without compromising safety or compliance.

A transparent, multi-method research framework combining expert interviews, technical standards review, and supply chain stress testing to underpin decision-focused insights

This analysis is informed by a multi-method research approach that combines primary expert interviews, technical literature review, and cross-functional process assessment to produce actionable findings. Primary inputs included structured discussions with supply chain leaders, product engineers, and regulatory professionals who provided qualitative insights into process constraints, material performance trade-offs, and regional sourcing behaviors. Technical literature and standards guidance were reviewed to ensure material assertions align with current sterilization and biocompatibility expectations, and to verify process capability characterizations for extrusion, injection molding, blow molding, thermoforming, and additive manufacturing.

To ensure robustness, the methodology integrated comparative supplier capability mapping and scenario-based stress testing for tariff and logistics disruptions. Cross-validation steps included triangulating interview observations with documented regulatory decisions and published technical notes, and assessing reproducibility of key engineering insights across multiple industry segments. Care was taken to avoid proprietary or vendor-specific claims, and analytical emphasis was placed on operational implications and decision-relevant trade-offs rather than quantitative market estimates. This approach yields a pragmatic foundation for planning and prioritization while preserving methodological transparency and traceability.

A synthesis of strategic priorities and capability imperatives that frames how companies should align engineering, regulatory, and procurement decisions for lasting resilience

In sum, the medical plastics sector is navigating a period of significant structural recalibration driven by material innovation, manufacturing precision demands, regulatory intensification, and evolving trade policy. Success in this environment depends on integrating material science with process capabilities, bolstering supplier governance, and adopting flexible manufacturing and sourcing strategies that can absorb policy shocks and sustain product quality. Companies that invest in sterilization-compatible polymers, micro-molding expertise, and digital traceability will be better positioned to meet the differentiated needs of hospitals, ambulatory centers, laboratories, and pharmaceutical manufacturers.

Looking forward, the most resilient organizations will be those that treat segmentation-driven product design, regional manufacturing strategy, and tariff risk management as interconnected components of a unified operating model. That integrated perspective enables faster innovation cycles, improved regulatory outcomes, and a more stable supply posture, all of which translate into better patient safety and more predictable commercial performance. The recommendations presented here are intended to serve as an actionable roadmap for leaders who must align engineering, regulatory, and procurement priorities under evolving market conditions.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Medical Plastics Market, by Product

  • 8.1. Blow Molded Components
  • 8.2. Films & Sheets
  • 8.3. Injection Molded Components
    • 8.3.1. Connectors & Fittings
    • 8.3.2. Housings & Casings
    • 8.3.3. Microfluidic Components
  • 8.4. Tubing

9. Medical Plastics Market, by Material Type

  • 9.1. Polycarbonate
  • 9.2. Polyethylene
  • 9.3. Polypropylene
  • 9.4. Polyvinyl Chloride
  • 9.5. Silicone

10. Medical Plastics Market, by Process Type

  • 10.1. Additive Manufacturing
  • 10.2. Blow Molding
  • 10.3. Extrusion
  • 10.4. Injection Molding
  • 10.5. Thermoforming

11. Medical Plastics Market, by Application

  • 11.1. Diagnostics
  • 11.2. Disposables & Consumables
    • 11.2.1. Catheters & Tubing
    • 11.2.2. Gloves & Drapes
    • 11.2.3. Needles & Cannulas
    • 11.2.4. Syringes & Cartridges
  • 11.3. Implants
  • 11.4. Medical Devices
    • 11.4.1. Diagnostic Devices
    • 11.4.2. Monitoring Devices
    • 11.4.3. Surgical Devices
    • 11.4.4. Therapeutic Devices
  • 11.5. Medical Packaging

12. Medical Plastics Market, by End User

  • 12.1. Ambulatory Surgery Centers
  • 12.2. Home Healthcare
  • 12.3. Hospitals
  • 12.4. Laboratories
  • 12.5. Pharmaceutical Manufacturers

13. Medical Plastics Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Medical Plastics Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Medical Plastics Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Medical Plastics Market

17. China Medical Plastics Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. BASF SE
  • 18.6. Celanese Corporation
  • 18.7. Covestro AG
  • 18.8. Dow Inc.
  • 18.9. DuPont de Nemours, Inc.
  • 18.10. Eastman Chemical Company
  • 18.11. Ensinger GmbH
  • 18.12. Evonik Industries AG
  • 18.13. Gerresheimer AG
  • 18.14. Minnesota Rubber & Plastics, Inc.
  • 18.15. Mitsubishi Chemical Corporation
  • 18.16. Nolato AB
  • 18.17. RAUMEDIC AG
  • 18.18. RTP Company
  • 18.19. Rochling SE & Co. KG
  • 18.20. Saudi Basic Industries Corporation
  • 18.21. Sekisui Chemical Co., Ltd.
  • 18.22. Solvay S.A.
  • 18.23. Teknor Apex Company
  • 18.24. Westlake Chemical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL MEDICAL PLASTICS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL MEDICAL PLASTICS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDED COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY FILMS & SHEETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CONNECTORS & FITTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOUSINGS & CASINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MICROFLUIDIC COMPONENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYCARBONATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY ADDITIVE MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY BLOW MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERMOFORMING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY CATHETERS & TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GLOVES & DRAPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY NEEDLES & CANNULAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SYRINGES & CARTRIDGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY IMPLANTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY MEDICAL PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 163. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. AFRICA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 172. AFRICA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 173. AFRICA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. AFRICA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 181. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 182. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. ASEAN MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 191. ASEAN MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 192. ASEAN MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASEAN MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. ASEAN MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 195. ASEAN MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 196. ASEAN MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 197. ASEAN MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. GCC MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. GCC MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 200. GCC MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 201. GCC MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. GCC MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. GCC MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GCC MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 205. GCC MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 206. GCC MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 214. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. EUROPEAN UNION MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. BRICS MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. BRICS MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. BRICS MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 223. BRICS MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 224. BRICS MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. G7 MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. G7 MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 227. G7 MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 228. G7 MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. G7 MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. G7 MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 231. G7 MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 232. G7 MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. G7 MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 234. NATO MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 235. NATO MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 236. NATO MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 237. NATO MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. NATO MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. NATO MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 240. NATO MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 241. NATO MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. NATO MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL MEDICAL PLASTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA MEDICAL PLASTICS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA MEDICAL PLASTICS MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA MEDICAL PLASTICS MARKET SIZE, BY INJECTION MOLDED COMPONENTS, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA MEDICAL PLASTICS MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA MEDICAL PLASTICS MARKET SIZE, BY PROCESS TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA MEDICAL PLASTICS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA MEDICAL PLASTICS MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA MEDICAL PLASTICS MARKET SIZE, BY MEDICAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA MEDICAL PLASTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)